Thank you for choosing Neurohealth Solutions. It is our goal to partner with you to provide an effective intervention for your patients who struggle with treatment resistant depression.
Only 25% of patients(1) with depression achieve remission with pharmacotherapy. For each medication failure, the likelihood of successful response decreases to less than 8% with the fourth medication. Combination pharmacotherapy does not fare much better. Additionally, dropout rates increase with sequential trials of medications, which generally take 6 to 8 weeks per drug.(2)
If a patient has a good response, it is recommended that they maintain drug therapy for 4 to 9 months for the first episode and even longer for subsequent episodes.(3) In contrast, clinical trials(4) demonstrated that Transcranial Magnetic Stimulation (TMS) without antidepressants achieved remission in 35% of cases with only a single 4-6 week treatment series.(5) TMS may even be used as a first line treatment option for depression.
Our Commitment to Excellence in Partnership
As you reflect on patients who would benefit from our services, consider your referral as a partnership with Neurohealth Solutions interventionists. We consider ourselves an extension of what you have to offer your patients by providing TMS and cognitive behavioral therapy. We want to help improve the quality of life your patients.
When you refer to Neurohealth Solutions you will get: Many TMS practices report well over 80% respond to TMS treatment and over 50% achieve remission with a combined single pharmacological therapy. Compared to drug therapy, side effects are rarer and much less severe with the most common for TMS being minor scalp irritation in less than 5% of patients.(6) One does not have to be concerned about serotonin syndrome, QT prolongation, drug interactions, or other complications of drug therapy. As opposed to electroshock therapy, there is no anesthesia, no cognitive impairment, and no recovery period with each TMS treatment.
1. A written report containing the assessment and
recommendations for your patient.
2. A mid-term report with empirically based measurement of
3. A discharge summary of final progress, services utilized
and your patient's response to our services.
In addition to TMS, each patient will have ongoing psychotherapy. We have gained expertise in a particular style of therapy called Mindfulness-Based Cognitive Therapy, which is especially impactful with treatment resistant depression and severe anxiety. We ask patients to participate in a minimum of eight psychotherapy sessions during the course of treatment. If they are seeing someone else in psychotherapy, we still ask the patient to come for four Mindfulness-Based Cognitive Therapy sessions.
(1) Trivedi (2006) Am J Psychiatry; Rush (2006) Am J Psychiatry; Fava (2006) Am J Psychiatry; McGrath (2006) Am J Psychiatry
(2) Qaseem A, et al. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008;149:725-7333
(3). Fitzgerald P., et al. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003;60:1002-10084
(4) Janicak, et al. J Clin Psychiatry, 2008; Janicak, et al. Brain Stimulation, 2010.
(5) Janicak, et al. J Clin Psychiatry, 2008; Janicak, et al. Brain Stimulation, 2010.
(6) Janicak, et al. J Clin Psychiatry, 2008; Janicak, et al. Brain Stimulation, 2010.